EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Drug-induced gastric motility disorders: A disproportionality analysis from the FAERS and CVARD databases

Zhiheng Qian iD, Ni Jiang

PLOS One · 12.06.2026 · 21 (6) · e0351731

DOI: 10.1371/journal.pone.0351731 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 12.06.2026. Verfasst von Zhiheng Qian und 1 weiteren Autor:innen. Beteiligte Einrichtung: Jinhua Central Hospital, Jinhua, China. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Gastrointestinal Motility, Gastric Emptying, Gastroesophageal Reflux. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Delayed gastric emptying and gastroesophageal reflux represent critical yet frequently underrecognized complications in hospitalized patients, particularly in the context of polypharmacy. While multiple medication classes have been implicated in disrupting gastrointestinal motility, the comprehensive risk spectrum of individual drugs remains poorly characterized. This study aimed to conduct a comprehensive disproportionality analysis to identify drugs associated with delayed gastric emptying and reflux using large-scale pharmacovigilance data.

Methods

We analyzed adverse event reports from the FDA Adverse Event Reporting System (FAERS; 2004–2025; n > 58 million) and validated findings against the Canada Vigilance Adverse Reaction Online Database (CVARD). Disproportionality analysis was performed using Reporting Odds Ratio (ROR), Proportional Reporting Ratio (PRR), and Bayesian Confidence Propagation Neural Network (BCPNN). Weibull time-to-onset analysis was conducted to characterize temporal patterns of adverse event onset.

Results

Among the top 50 drugs screened, 20 demonstrated positive signals across all three algorithms. Glucagon-like peptide-1 (GLP-1) receptor agonists exhibited the strongest associations with gastric motility disorders, with semaglutide showing the highest ROR for impaired gastric emptying (ROR: 80.27; 95% CI: 76.39–84.34), validated in CVARD (ROR: 54.17). Insulin formulations, particularly insulin degludec (ROR: 18.90), bisphosphonates, angiotensin receptor blockers, and trofinetide also demonstrated significant signals. Weibull analysis revealed divergent temporal patterns, ranging from early-onset (trofinetide: median 6.6 days) to late-onset (immunoglobulin G: median 535.1 days).

Conclusion

This study identifies a broad spectrum of drug-associated gastric motility disorders with distinct temporal profiles. These findings provide evidence-based priorities for enhanced pharmacovigilance and inform clinical decision-making to mitigate this preventable cause of morbidity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adverse Drug Reaction Reporting SystemsGastrointestinal MotilityGastric EmptyingGastroesophageal RefluxDrug-Related Side Effects and Adverse ReactionsHumansDatabases, FactualUnited StatesPharmacovigilanceBayes TheoremCanadaUnited States Food and Drug Administration

Autor:innen und Institutionen

  • Jinhua Central Hospital, Jinhua, China.

ORCID-Profile: Zhiheng Qian

Zitieren

APA

Qian, Z., & Jiang, N. (2026). Drug-induced gastric motility disorders: A disproportionality analysis from the FAERS and CVARD databases. PLOS One, 21(6), e0351731. https://doi.org/10.1371/journal.pone.0351731

Vancouver

Qian Z, Jiang N. Drug-induced gastric motility disorders: A disproportionality analysis from the FAERS and CVARD databases. PLOS One. 2026;21(6):e0351731. doi:10.1371/journal.pone.0351731

BibTeX
@article{Qian2026,
  author = {Qian, Zhiheng and Jiang, Ni},
  title = {Drug-induced gastric motility disorders: A disproportionality analysis from the FAERS and CVARD databases},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {6},
  pages = {e0351731},
  doi = {10.1371/journal.pone.0351731}
}
Kostenlos starten →